| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2001 | DE10006578A1 Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren Use of compatible solutes as inhibitors of the enzymatic degradation of macromolecular biopolymers |
| 08/23/2001 | DE10005936A1 Creme, insbesondere zur äußeren Anwendung auf der Nasenhaut Cream, especially for external use on the skin of the nose |
| 08/23/2001 | DE10002820A1 Aminopeptidasen-Inhibitor Aminopeptidase inhibitor |
| 08/23/2001 | CA2765218A1 Antiadhesive carbohydrates comprising a terminal uronic acid unit containing a carbon-carbon double bond |
| 08/23/2001 | CA2651825A1 Substituted arylpyrazines |
| 08/23/2001 | CA2400862A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/23/2001 | CA2400860A1 Aminoalcohol derivatives |
| 08/23/2001 | CA2400857A1 Skin preparations for external use |
| 08/23/2001 | CA2400845A1 Sustained-release preparation of physiologically active compound slightly soluble in water and production process and use of the same |
| 08/23/2001 | CA2400640A1 Phenoxyalkylamine derivatives useful as opioid .delta. receptor ligands |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400631A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | CA2400619A1 Purine derivatives |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | CA2400405A1 Protection of the female reproductive system from natural and artificial insults |
| 08/23/2001 | CA2400374A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400353A1 Method for reducing or eliminating smoking |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400290A1 A method for synthesizing leflunomide |
| 08/23/2001 | CA2400274A1 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/23/2001 | CA2400264A1 Cancer remedy comprising anthranilic acid derivative as active ingredient |
| 08/23/2001 | CA2400206A1 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation |
| 08/23/2001 | CA2400197A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | CA2400178A1 Nail lacquer pharmaceutical composition |
| 08/23/2001 | CA2400136A1 Weight loss induced by reduction in neuropeptide y level |
| 08/23/2001 | CA2400021A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | CA2399947A1 Phosphororganic compounds and the use thereof |
| 08/23/2001 | CA2399810A1 Modulation of bone formation |
| 08/23/2001 | CA2399757A1 Polypeptoid pulmonary surfactants |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2399219A1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 08/23/2001 | CA2399198A1 Motilide compounds |
| 08/23/2001 | CA2399147A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | CA2398937A1 Substituted arylpyrazines |
| 08/23/2001 | CA2398872A1 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2398706A1 Cytoprotective steroids (ii) |
| 08/23/2001 | CA2398691A1 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 08/23/2001 | CA2398628A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, andantagonists thereof |
| 08/23/2001 | CA2398063A1 Male contraceptive formulation comprising norethisterone |
| 08/23/2001 | CA2397768A1 Use of alpha 1a adrenoceptor agonists with alpha 1b and alpha 1d antagonism for the treatment of stress urinary incontinence |
| 08/23/2001 | CA2397651A1 Amine derivatives for the treatment of apoptosis |
| 08/23/2001 | CA2397560A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | CA2397458A1 Improvements in or relating to solubilisation of flavonols |
| 08/23/2001 | CA2397233A1 Biarylcarboxamides |
| 08/23/2001 | CA2395862A1 Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production |
| 08/23/2001 | CA2395854A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/23/2001 | CA2371419A1 Polyhydroxylated benzene-containing compounds |
| 08/23/2001 | CA2337616A1 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 08/22/2001 | EP1126025A2 Oligonucleotide modulation of protein kinase C |
| 08/22/2001 | EP1126022A2 Method of preserving white blood cells with CLA |
| 08/22/2001 | EP1125977A1 Dermatan sulfate composition as antithrombotic |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
| 08/22/2001 | EP1125942A1 Derivatives of 6-amino or 6-hydrazinosulfonyl-3-quinolyl phosphonic acids, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2001 | EP1125941A1 Derivatives of 6-sulfamoyl-3-quinolyl phosphonic acids, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2001 | EP1125940A1 Derivatives of aryl or heteroaryl quinolinylphosphonic acids, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2001 | EP1125938A1 Protein kinase inhibitors for treatment of neurological disorders |
| 08/22/2001 | EP1125936A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases |
| 08/22/2001 | EP1125932A2 Substituted thiazoles for the treatment of inflammation |
| 08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
| 08/22/2001 | EP1125925A1 Amine derivatives for the treatment of apoptosis |
| 08/22/2001 | EP1125924A1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization |
| 08/22/2001 | EP1125585A1 Remedies for immunological diseases |
| 08/22/2001 | EP1125583A1 Use of compatible solutes as inhibitors of the enzymatic degradation of macromolecular biopolymers |
| 08/22/2001 | EP1125582A2 Use of estrogen agonists / antagonists for the treatment of sexual dysfunction |
| 08/22/2001 | EP1125581A1 Use of sertraline to treat panic disorder |
| 08/22/2001 | EP1125580A2 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 08/22/2001 | EP1125579A2 Uses of agrp-melanocortin receptor binding modulating compounds |
| 08/22/2001 | EP1125578A1 Tape material for transcutaneous absorption |
| 08/22/2001 | EP1125575A1 Perfusate preparation for ophthalmic operation |
| 08/22/2001 | EP1125507A1 Inulin products with improved nutritional properties |
| 08/22/2001 | EP1124982A1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i |
| 08/22/2001 | EP1124980A2 Method for the production of quercetin and isoquercetin derivatives |
| 08/22/2001 | EP1124978A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124953A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/22/2001 | EP1124950A2 p53 ANTISENSE AGENT AND METHOD |
| 08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
| 08/22/2001 | EP1124854A2 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124842A1 Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumors |
| 08/22/2001 | EP1124841A1 Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124839A2 Nucleosides with anti-hepatitis b virus activity |
| 08/22/2001 | EP1124837A2 Novel macrolide antibiotics |
| 08/22/2001 | EP1124831A2 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation |
| 08/22/2001 | EP1124829A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/22/2001 | EP1124824A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2001 | EP1124823A1 Thrombin inhibitors |
| 08/22/2001 | EP1124822A1 Thrombin inhibitors |
| 08/22/2001 | EP1124821A1 Compounds |
| 08/22/2001 | EP1124820A1 Lipoic acid derivatives and their use in treatment of disease |
| 08/22/2001 | EP1124817A1 Method of preparing delta-9-tetrahydrocannabinol esters |
| 08/22/2001 | EP1124815A1 Method for producing luteolin and luteolin derivatives |
| 08/22/2001 | EP1124814A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |